Sign in

CIK 0001544227

  • Non-accelerated filer
  • Smaller reporting company

Tempest Therapeutics, Inc.

Sign in to watch
Ticker
TPST
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
451472564
Phone
+1 415-798-8589
Business address
2000 SIERRA POINT PARKWAY, SUITE 400, BRISBANE, CA, 94005
Former names
Millendo Therapeutics, Inc., OvaScience, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2017-03-02 Couturier Christophe Chief Financial Officer Grant or award · Stock Option (right to buy) +45,750 45,750
2017-01-05 Couturier Christophe Chief Financial Officer Grant or award · Stock Option (right to buy) +100,000 100,000
2016-12-23 Couturier Christophe Chief Financial Officer Grant or award +300 $1.44 $431 50,900
2016-09-08 Couturier Christophe Chief Financial Officer Grant or award +50,000 50,600
2016-09-08 Couturier Christophe Chief Financial Officer Grant or award · Stock Option (right to buy) +200,000 200,000

Page 1 of 1 · 5 trades